For the HER 2 + tumor subtype, all genes implicated were located at chromosome 17q, where we distinguished relevant pathways such as the ERBB2, ERBB, and epidermal growth factor receptor (EGFR) or the negative regulation of ERBB (Figure 5E). This evidence concerns the gene EGFR and neoplasm.